Form 4: Coliseum Capital Management Increases Stake in Owens & Minor
SEC Form 4
Coliseum Capital Management and related entities have increased their holdings in Owens & Minor through a series of open market purchases.
Summary
- Coliseum Capital Management, LLC, along with related entities, has reported changes in their beneficial ownership of Owens & Minor Inc. (OMI) common stock.
- Between April 8, 2025, and April 10, 2025, the group purchased a total of 410,000 shares of OMI common stock.
- The purchases were made at weighted average prices ranging from $7.19 to $7.96 per share.
- Following these transactions, Coliseum Capital Management and related entities beneficially own 11,562,955 shares of OMI common stock.
- The shares are held directly by Coliseum Capital Partners, L.P. (CCP) and a separate account investment advisory client of CCM.
- Christopher S. Shackelton and Adam Gray, managers of CCM and CC, disclaim beneficial ownership except to the extent of their pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a report of stock purchases, which can be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.
Positives
- Coliseum Capital Management's increased investment in Owens & Minor could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
This filing reflects investment activity in the healthcare distribution sector, where companies like Owens & Minor operate. Monitoring such filings provides insights into investor sentiment and potential strategic shifts within the industry.
Comparison to Industry Standards
- Comparing Coliseum Capital's increased stake in Owens & Minor to similar investments in competitor companies like Cardinal Health (CAH) or McKesson (MCK) could provide insights into relative valuation and growth expectations.
- Analyzing the investment's size and timing relative to industry trends, such as healthcare consolidation or supply chain disruptions, can offer a broader perspective.
- Benchmarking the purchase prices against historical trading data and analyst targets for OMI can help assess the attractiveness of the investment.
Stakeholder Impact
- The increased stake by Coliseum Capital Management could positively influence shareholder confidence.
- The transactions do not appear to have any immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 04/08/2025 | Purchase of 105,000 shares of Common Stock at a weighted average price of $7.96. |
| 04/09/2025 | Purchase of 225,000 shares of Common Stock at a weighted average price of $7.39. |
| 04/10/2025 | Purchase of 80,000 shares of Common Stock at a weighted average price of $7.19. |
| 04/10/2025 | Date of filing of the SEC Form 4. |
Keywords
Owens & Minor, Coliseum Capital Management, Beneficial Ownership, OMI, Stock Purchase, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.